Metraipolis › archive › dc_da0f2a70264e

An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial — Europe PMC PMID:42443515

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42443515
DOI
10.1038/s41591-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-10-08T04:30:49.267Z
SHA-256 of the archived text
6698ef5c5bdb6e2117e6d4da46d89efbc8793d9b0b506a9e086548b5d0b62ab1
Stable URL of this page
https://metraipolis.com/documento/dc_da0f2a70264e

How to cite

An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial — Europe PMC PMID:42443515 — Europe PMC (en), https://europepmc.org/article/MED/42443515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da0f2a70264e (Metraipolis archive dc_da0f2a70264e, sha256 6698ef5c5bdb6e2117e6d4da46d89efbc8793d9b0b506a9e086548b5d0b62ab1)
BibTeX
@misc{dcda0f2a70264e,
  title = {An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial — Europe PMC PMID:42443515},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42443515},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da0f2a70264e; sha256 6698ef5c5bdb6e2117e6d4da46d89efbc8793d9b0b506a9e086548b5d0b62ab1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42443515. Agents can read the archived copy with the MCP tool read_document.